KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Other Operating Expenses (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Other Operating Expenses for 11 consecutive years, with $548.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 35.68% year-over-year to $548.3 million, compared with a TTM value of $1.9 billion through Dec 2025, up 20.12%, and an annual FY2025 reading of $1.8 billion, up 21.75% over the prior year.
  • Other Operating Expenses was $548.3 million for Q4 2025 at Medpace Holdings, up from $511.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $548.3 million in Q4 2025 and bottomed at $182.8 million in Q1 2021.
  • Average Other Operating Expenses over 5 years is $335.7 million, with a median of $346.7 million recorded in 2023.
  • The sharpest move saw Other Operating Expenses skyrocketed 36.31% in 2021, then rose 6.79% in 2025.
  • Year by year, Other Operating Expenses stood at $221.8 million in 2021, then grew by 25.85% to $279.2 million in 2022, then increased by 29.71% to $362.1 million in 2023, then increased by 11.58% to $404.1 million in 2024, then soared by 35.68% to $548.3 million in 2025.
  • Business Quant data shows Other Operating Expenses for MEDP at $548.3 million in Q4 2025, $511.3 million in Q3 2025, and $470.2 million in Q2 2025.